The selected channel has been deleted from your list of favorites.
Boston, MA USA

Our News on Newswise
View All >

Newswise: 66fff43238b00_WeightedblanketpatientIrmaPascarellawithCheriHermannBSNRNOCNphotobyLyndaChubbuck.jpg

Dana-Farber Cancer Institute Delivers ‘Simple Immediate Impact’ to Patient Comfort Using Weighted Blankets

Weighted blankets are available to patients receiving infusions at all Dana-Farber locations as the result of a project led by staff nurse Cheri Hermann, BSN, RN, OCN. The initiative dates to March 2020, when she observed heightened anxiety in...
4-Oct-2024 9:05 AM EDT Add to Favorites

Dana-Farber Cancer Institute Leads the Launch of IGNITE Consortium to Eradicate Health Inequities in Pediatric Cancer Care

In a bold step toward addressing the stark disparities in pediatric cancer care, Dana-Farber Cancer Institute is taking the lead in launching IGNITE—the first national, pediatric hematology-oncology health equity research consortium. This...
26-Sep-2024 9:30 AM EDT Add to Favorites

Newswise: 66e454aacb966_YawkeyEvening.jpg

Antibody-Drug Conjugate Found Effective Against Brain Metastases in Patients with HER2-Positive Breast Cancer

A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced HER2-positive breast cancer. Research led by...
13-Sep-2024 11:05 AM EDT Add to Favorites

Newswise: 66e45358ab643_DanaFarberBuilding.jpg

Repeat Immune Checkpoint Inhibitor Therapy Not Recommended for Advanced Kidney Cancer

In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the addition of the immune checkpoint inhibitor (ICI) nivolumab to treatment with tivozanib for patients with advanced clear...
13-Sep-2024 10:05 AM EDT Add to Favorites

Newswise: 66ddf78d827d8_DanaFarberBuilding.jpg

Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024

Novel treatments, including targeted therapies and antibody drug conjugates, as well as research into improving quality of life for patients with breast cancer, headline studies led by Dana-Farber Cancer Institute and presented at the European...
9-Sep-2024 8:05 AM EDT Add to Favorites

Antibody-Drug Conjugate Highly Effective in Preventing Recurrence in Patients with Early Stage HER2+ Breast Cancer, Trial Finds

• 97% of HER2+, early-stage patients treated with trastuzumab emtansine (T-DM1) were free of cancer recurrence five years after treatment • Prognostic test (HER2DX) shown helpful in identifying patients at greatest risk for recurrence
25-Jun-2024 12:05 PM EDT Add to Favorites

Newswise: 667afcbe14e73_BuildingExteriorevening.jpg

Researchers report first effective use of immunotherapy for most common subtype of colorectal cancer

These clinical trial results point to the first safe and effective use of immunotherapy for patients with microsatellite stable colorectal cancer, the most common subtype of the disease. The encouraging results of this phase I trial have prompted...
25-Jun-2024 1:05 PM EDT Add to Favorites

Newswise: 66718e78359c0_DanaFarberBuilding.jpg

Anti-inflammatory drug celecoxib could reduce risk of colon cancer recurrence for a subset of patients

An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery lived significantly longer and had longer disease-free...
18-Jun-2024 10:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Movie release prompts national conversation about colorectal cancer in the Black community

Marvel Studios’ movie, “Black Panther: Wakanda Forever,” is the highly anticipated sequel to “Black Panther,” hitting theaters on November 11th. It will premiere without “Black Panther” star Chadwick Boseman, who passed away in 2020...
8-Nov-2022 3:05 PM EST

Newswise: Yawkey Building 2.jpg

Dana-Farber to hold a discussion for cancer patients and survivors about the Covid-19 vaccine

Dana-Farber Cancer Institute is having a virtual discussion for cancer patients and survivors about the Covid-19 vaccine on January 27, 2020 at 5 pm.
25-Jan-2021 12:05 PM EST

Newswise: Dr.JeffreyMeyerhardtFINAL.jpg

Colorectal Cancer: Five Things You Need To Know

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

Newswise: AnnPartridge.jpg

Leading Breast Cancer Expert Available to Comment on Young Women with Breast Cancer

11-Nov-2013 5:00 PM EST

Newswise: PF_SOG_7837.jpg

National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support

17-Sep-2013 3:00 PM EDT

Newswise: Dr.Haddadphoto.jpg

Vaccinating Children Against HPV?

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

Newswise: Andrea_Patenaude.jpg

Prophylactic Double Mastectomy: Angelina Makes a Private Choice a Public Issue

24-May-2013 3:00 PM EDT

Newswise: Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

See All Experts

Our YouTube Videos
View All >

About

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Experts

Facebook

close
0.39884